Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Hematology, Transfusion and Cell Therapy|November 19, 2021
Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumorsMirella Nardo, Tatiane C Motta, Leandro M Colli, et al.
Fundamental & Clinical Pharmacology|October 15, 2013
Cannabidiol reverses the mCPP-induced increase in marble-burying behaviorMirella Nardo, Plinio C Casarotto, Felipe V Gomes, et al.
Nature Reviews. Clinical Oncology|December 3, 2024
Synthetic lethal strategies for the development of cancer therapeuticsNatalie Y L Ngoi, David Gallo, Carlos Torrado, et al.
Gynecologic Oncology|April 11, 2022
Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysisJi Son, Goldy C George, Mirella Nardo, et al.
Journal of Immunotherapy and Precision Oncology|April 11, 2025
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket TrialMirella Nardo, Camila Braganca Xavier, Bettzy Stephen, et al.
NPJ Precision Oncology|May 25, 2023
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastomaBlessie Elizabeth Nelson, Neha K Reddy, Jason T Huse, et al.
Cell Reports. Medicine|December 20, 2023
Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancersMirella Nardo, Mohamed A Gouda, Blessie E Nelson, et al.
Journal of Global Oncology|September 11, 2018
Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian PopulationPedro Isaacsson Velho, Mirella Nardo, Manoel Carlos Leonardi de Azevedo Souza, et al.
Autopsy & Case Reports|August 3, 2019
Primary splenic angiosarcoma: a rare entity often associated with rupture and hemoperitoneumMatheus Dalben Fiorentino, Jean Michel Correia Monteiro, Renata Elisie Barbalho de Siqueira, et al.
Pathology Oncology Research : POR|June 26, 2020
Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell CarcinomaGuilherme Nader Marta, Pedro Isaacsson Velho, Renata R C Bonadio, et al.
Pageof 2